The Use of Polyethylene Glycol in the Pediatric Population (R01)

Quick Facts

Due DateJuly 15, 2014 (Tuesday)
Award AmountUp to $ 325,000
Category of Funding ActivityConsumer Protection
Food and Nutrition
Health
Eligible Applicants
  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities/Indian housing authorities
  • Native American tribal organizations (other than Federally recognized tribal governments)
  • Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education
  • Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others - Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are allowed.

Program Description

The purpose of the proposed study is to better understand the extent of pediatric accumulation of low molecular weight (LMW) species that may be found in PEG 3350 products (e.g., ethylene and diethylene glycol) and of PEG 3350 metabolites. PEG 3350 products are used in the treatment of constipation. If present in the product when administered and/or produced in the gut and absorbed, these metabolites and LMW species may accumulate in children taking PEG 3350 products -- potentially leading to adverse events. This is an important first step needed to begin to understand if PEG 3350 use contributes to adverse events in children due to the absorption of these species.

General Information

Funding Opportunity NumberRFA-FD-14-088
Funding Opportunity TitleThe Use of Polyethylene Glycol in the Pediatric Population (R01)
Opportunity CategoryConsumer Protection
Food and Nutrition
Health
Funding Instrument TypeGrant
Category ExplanationNot Available
Number of Awards1
Cost Sharing or Matching RequirementNo
Posted DateJune 4, 2014 (Wednesday)
Application Due DateJuly 15, 2014 (Tuesday)
Application Archive DateAugust 14, 2014 (Thursday)
Total Program Funding$ 325,000
Award AmountUp to $ 325,000
CFDA Number
  • 93.103 - Food and Drug Administration_Research

Eligible Applicants

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities/Indian housing authorities
  • Native American tribal organizations (other than Federally recognized tribal governments)
  • Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education
  • Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others - Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are allowed.

Contact Information

Agency NameDepartment of Health and Human Services
Program Information WebsiteFull Announcement RFA-FD-14-088
ContactOffice: Food & Drug Administration
Lisa Ko
Grants Management Specialist
lisa.ko@fda.hhs.gov

Search Federal Grants

Application Due Date:
-